Upcoming event
05
Nov
06
Nov
VASCERN Days 2026
The 2026 International Drug Repurposing Conference (iDR26) will take place on 12–13 May 2026 in Brussels, Belgium. Organised by the REMEDi4ALL project in partnership with Beacon for Rare Diseases, this major global forum brings together researchers, patient organisations, industry, regulators, funders, and health technology assessment bodies to advance drug repurposing for rare and common conditions.
Conference focus and topics
iDR26 will explore how drug repurposing can deliver faster, more affordable therapies for patients, with a strong focus on patient-centric medicine development and equitable access. Sessions will cover:
- AI-driven drug discovery technologies and biosimilars for repurposing.
- Regulatory and policy frameworks to support repurposed medicines.
- Case studies from successful public-private partnerships and rare disease projects.
- Strategies to bridge research, clinical development, and patient needs.
The conference will include four thematic tracks designed to connect scientific innovation with regulatory policy and community engagement.
Who should attend
iDR26 is aimed at a broad international audience, including:
- Researchers in drug repurposing and translational science.
- Patient organisations and advocates interested in new therapies.
- Pharmaceutical and biotech industry representatives.
- Regulators, health technology assessment (HTA) bodies, and policymakers.
- Funders, impact investors, and research infrastructure partners.
Registration:
Registration and full conference details are available on the Remedi4All website: click here